Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1385 of 6351
-
Can 3D-printed guides tame the toughest spine screws?
Knowledge-focused OngoingThis retrospective, single-center observational study evaluates the clinical safety and neurophysiological performance of patient-specific MySpine guides (Medacta International) for pedicle screw placement in patients undergoing instrumented spinal surgery. Particular attention i…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis research is being done to test a combination of two drugs, Izalontamab Brengitecan (iza-bren) and Adagrasib, in patients with advanced KRAS G12C-mutant NSCLC that hasn't responded to other treatments. The purpose is to see if this combination works better than existing treat…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can VR games restore lost vision in young brain tumor survivors?
Symptom relief Not yet recruitingEvaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly im…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
A patch that may rescue Post-Night-Shift sleep – tested in doctors
Symptom relief By invitation onlyA Phase 1 Feasibility Study of the SuperPatch REM Patch for Post-Night-Shift Sleep Recovery in NHS Doctors
Sponsor: SuperPatch Limited LLC • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can stitches replace nasal packing for easier septoplasty recovery?
Symptom relief Recruiting nowThe goal of this clinical trial is to see the outcomes of the two techniques used after septoplasty in terms of postoperative nasal pain and nasal bleeding in the patients with deviated nasal septum of 18 to 50 years of age presented in a tertiary care hospital. The main question…
Sponsor: Ghazal Iftakhar • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Shockwaves or magnets? new trial tests two therapies for Women's sexual health
Symptom relief Recruiting nowThis is a prospective, three-arm, parallel-group, assessor-blinded randomized controlled trial designed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) combined with pelvic floor muscle training (PFMT), pulsed electromagnetic field stimulation (PEMF) combi…
Sponsor: Benha University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New antibiotic OMN6 tested against tough lung infection
Disease control Recruiting nowThis is a phase 2a, multinational, multicenter, double-blind, randomized, placebo-controlled, dose-ranging safety, tolerability and PK study in patients with HABP (Hospital Acquired Bacterial Pneumonia) or VABP (Ventilator Associated Bacterial Pneumonia) caused by ABC to identify…
Phase 2 • Sponsor: Omnix Medical Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy injection aims to control rare brain disease in children
Disease control Not yet recruitingA phase I/II clinical study to evaluate the tolerance, safety and efficacy of VGN-R08b intracerebroventricular injection in patients with type III Gaucher's disease
Phase 1/2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Personalized combo therapy aims to overcome drug resistance in kidney cancer
Disease control Not yet recruitingGiven the significant challenge of drug resistance in patients with advanced renal cell carcinoma (RCC) despite standard treatment, this study aims to translate preclinical findings into clinical practice, preliminarily evaluating the safety, tolerability, and preliminary efficac…
Phase 1/2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowIn this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to p…
Phase 2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could a quick ketamine infusion lift depression in ICU patients?
Symptom relief Recruiting nowDepressive symptoms are common among patients admitted to the intensive care unit (ICU) and may adversely affect recovery, participation in care, treatment adherence, quality of life, and outcomes after critical illness. Conventional antidepressants have limited utility for rapid…
Phase 2 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could a common diabetes drug boost immunotherapy in Hard-to-Treat cancers?
Disease control Recruiting nowThis study is testing whether adding the drug sitagliptin to the standard immunotherapy pembrolizumab is safe and may help people with advanced melanoma or advanced renal cell carcinoma (kidney cancer) whose cancer has stopped responding to prior PD-1 or PD-L1 immunotherapy. The…
Phase 1 • Sponsor: Fernando Maciel Barbosa • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New study tackles double malnutrition burden in guatemala
Disease control Recruiting nowGlobally, populations are experiencing increases in the double burden of malnutrition, commonly defined as maternal overweight/obesity and child stunting in the same household. This study will evaluate an integrated intervention combining food supplementation for pregnant and pos…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for elderly lung cancer: One-Drug immunotherapy trial launches
Disease control Recruiting nowThis prospective clinical study aims to evaluate and observe the efficacy and safety of Serplulimab Monotherapy in Elderly Patients with NSCLC and PD-L1 TPS ≥ 50% using a multicenter, single-arm, phase II design. The study is planned to be conducted in Shaanxi Province, China, w…
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for recurrent ovarian cancer? early trial combines novel PARP inhibitor with chemo
Disease control Recruiting nowThis is a multicenter, open-label Phase Ia/b study on the safety and efficacy of the combination of NMS-03305293 and topotecan in patients with recurrent ovarian cancer, with dose-limiting toxicity (DLT) escalation. The aim of this study is to determine the safety and tolerabilit…
Phase 1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a 4-Week radiation course be as good as 5 weeks for prostate cancer?
Disease control Recruiting nowStudy Overview This research compares two types of post-operative salvage radiotherapy (SRT) for men with prostate cancer who have had surgery but show signs of recurrence (detectable PSA). The goal is to see if a shorter treatment schedule is as safe and effective as the standar…
Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug trial aims to tame muscle weakness in myasthenia gravis
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New insulin pump aims to tame blood sugar swings
Disease control Recruiting nowThis multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a nerve drug boost GIST treatment? early trial begins.
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of the drug fampridine can be given safely together with imatinib (Gleevec) in patients with gastrointestinal stromal tumor (GIST) with a DNA mutation in exon 11 of the KIT gene. The main questions this study aims to answer a…
Phase 1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can acceptance and commitment therapy ease chronic pain as well as CBT?
Symptom relief OngoingThis study is evaluating whether Acceptance and Commitment Therapy (ACT) helps adults with chronic non-malignant pain (pain lasting 3 months or longer that is not caused by cancer). Sixty adult participants (ages 18-60) were randomly placed into one of three groups: ACT, Cognitiv…
Sponsor: GIFT University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC